# Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration

> **NCT04362449** · PHASE2 · UNKNOWN · sponsor: **Imperial College Healthcare NHS Trust** · enrollment: 30 (estimated)

## Conditions studied

- Gallbladder Cancer

## Interventions

- **COMBINATION_PRODUCT:** Shortened hydration time and dispensary of Akynzeo
- **COMBINATION_PRODUCT:** Standard of care

## Key facts

- **NCT ID:** NCT04362449
- **Lead sponsor:** Imperial College Healthcare NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-02
- **Primary completion:** 2023-02-02
- **Final completion:** 2023-02-02
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04362449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04362449, "Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04362449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*